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A speciﬁc tissue of interest for cryopreservat ion is the articular cartilage of the human knee joint for 
two major reasons: (1) clinically, there exists an untapped potential for cryopreserved cartilage to be
used in surgical repair/recons truction/replacement of injured joints because of the limited availability 
of fresh donor tissue and, (2) scientiﬁcally, successful cryopreservation of cartilage, an avascular tissue 
with only one cell type, is considered a stepping stone for transition from biobanking cell suspensions 
and small tissue slices to larger and more complicated tissues. For more than 50 years, a great deal of
effort has been directed toward understanding and overcoming the challenges of cartilage preservation.
In this article, we focus mainly on studies that led to the ﬁnding that vitriﬁcation is an app ropriate 
approach toward successful preservation of cartilage. This is follow ed by a review of the studies on the 
main challenges of vitriﬁcation, i.e. toxicity and diffusion, and the novel approaches to overcome these 
challenges such as liquidus tracking, diffusion modeling, and cryoprotective agent cocktails, which have 
resulted in the recent advancements in the ﬁeld.
 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Introductio n
Articular cartilage is the white dense material covering the ends 
of the bones in the articulating joints, such as the knee. Compared 
to most other tissue types in the human body, articular cartilage is
a simple tissue containing only one cell type, called chondrocytes ,
with no vascular, lymphatic or nervous system. Articular cartilage 
consists of a collagen network, predominantl y of collagen type II,
developed speciﬁcally to respond to the mechanical forces on the 
joint. Packed within this collagen network are proteoglyca ns that 
provide the hydraulic -like resistance to mechanical forces. These 
proteoglyca ns are hydrophi lic resulting in a large proportion of
the weight and volume of articular cartilage being water (varying
from 65% to 80% depending on the type and depth of the cartilage ).
Chondrocytes are the lone cell type present in cartilage, and are 
scattered throughout the matrix with a denser, horizontally 
aligned distribut ion close to the contact surface (tangential zone).
Further from the surface, the density of chondrocy tes decreases 
and they become randomly distribut ed. Finally, closer to the 
tide-mark (bone-cartilage boundary) the cells are more vertically w article was funded by the 
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Y-NC-ND license.aligned. Chondrocytes produce and maintain the extracellular ma- 
trix precursor material including the collagen and the proteogly- 
cans that also change in distribution and orientation from 
superﬁcial to deep within the cartilage matrix. The absence of a
vascular supply in articular cartilage means that the cells receive 
nutrients and discharge waste material by diffusion through the 
extracellular matrix, from and to the synovial ﬂuid, respectively .
As a result, articular cartilage has a very limited ability to self-heal 
and joint injuries with articular cartilage damage can lead to carti- 
lage degeneration and subsequent osteoarthritis with signiﬁcant
personal and socioeconomic costs [93].
Cartilage replacemen t or repair can be indicated for a number of
medical conditions including: avascular necrosis/osteo chondritis 
dissecans , traumatic injuries, epiphyse al tumors and arthritis.
These conditions do not have good non-surgical or surgical options 
to restore joint function and, if left untreated, they lead to joint 
instabilit y, deterioration and subsequent osteoarthrit is. Arthritis 
is the most common cause of disability in North America and 
osteoarthr itis is the most common form of arthritis. More than 
20 million people in the US alone deal with severe limitations in
function on a daily basis due to arthritis, which results in more 
than 1 million hospitalizati on cases, and costs a total of $100 bil- 
lion US every year [1].
Surgical treatment options depend on the type and size of the 
cartilage lesion. Small lesions less than 1 cm in diameter typically 
can be compensated by the surrounding cartilage but not always.
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require surgical intervention. The most common cell-based inter- 
ventions are microfractu re [97,98], autologous chondrocyte 
implantation (ACI) [15,16], and matrix associated ACI (MACI)
[11,66]. There are many reports of these surgical techniques pro- 
viding some positive results but they are unable to reproduce the 
complex structure of the articular cartilage matrix resulting in bio- 
mechanicall y inferior ﬁbrocartilage or ‘‘hyaline-l ike’’ cartilage . It is
possible that these inferior cartilage repair tissues will not function 
well in the long-term. Another surgical treatment option is mosa- 
icplasty (osteochondral autografts) which consists of taking carti- 
lage from one area of the joint and moving it to the defect. This 
will restore the normal cartilage matrix structure in the injured 
area at the cost of removing it from a previously healthy area of
the joint. All of these techniqu es can provide some relief in small 
to medium size defects but they are not able to treat large defects,
including whole joints, effectively . The only biologic technique that 
can restore partial [102,103], or whole joints [9,19,36] is osteo- 
chondral allografting [38] which entails transplanting bone and 
cartilage from a donor patient into a recipient patient. In older pa- 
tients, synthetic total joint replacemen t is a viable option for more 
sedentary, low activity patients. Unfortunately, this is not as good 
an option in younger or active patients because the synthetic joint 
replacemen ts tend to fail after 7–15 years. Osteochond ral trans- 
plantation is a possible option for these younger, more active pa- 
tients but access to fresh tissue is extremely difﬁcult.
Fresh osteochondral transplants provide the best case scenario 
for cell viability and matrix integrity but fresh transplant is fraught 
with technical difﬁculties. This tissue should be harvested within 
24 h of death of the donor and is typically transplante d within 
48–72 h after harvest [37]. This time frame is too short to perform 
the extensive testing required to rule out the possibility of trans- 
mission of infectious diseases. Consideri ng that joint injury and 
osteoarthrit is are not life threatening , the risk may not be war- 
ranted. Another signiﬁcant technical difﬁculty is that matching 
for size and contour, which are important factors for long term suc- 
cessful outcomes, is extremely difﬁcult on such short notice [19].
Making arrangements for complicated joint replacemen t surgery 
on short notice can result in logistic problems in arranging the 
operating room, appropriate surgical staff, surgeon and even the 
patient. Currently, blood/HLA typing is not performed as articular 
cartilage is considered immune privileged. That said, the cartilage 
is transplante d on bone and there can be minor immune reaction 
to the transplanted bone. This is typically self-limited as the trans- 
plant bone is replaced with host bone if only a small amount is
transplante d. In the future, blood/HLA typing may be employed 
to limit the immune reaction which adds another layer of complex- 
ity to performing this surgery on short notice. To address these is- 
sues, hypothermic storage at 4 C for a limited time (28–42 days) is
used to increase the supply [41,110]. Unfortunately, tissue deteri- 
oration begins after only 7–14 days [65]. The lack of normal 
mechanical stimulation impairs the efﬁciency of nutrient and 
waste transport, and decrease s cytokine secretion (IL-1 and TNF- 
a) as reviewed by Kim, Teng and Dang [58]. The ability to store 
articular cartilage indeﬁnitely would allow for precise size/contour 
matching, pre-surgical planning, testing for infectious diseases,
possible blood typing and appropriate surgical timing for the pa- 
tient, operating staff and surgeon.
Successful cryopres ervation of articular cartilage , by either clas- 
sical methods or vitriﬁcation, can extend the availability of the tis- 
sue and allow long-term banking of articular cartilage. Successful 
cryopreserv ation and banking of articular cartilage will enable eas- 
ier and more efﬁcient utilization of straightforwar d protocols for 
transplanta tion. From a cryopres ervation perspective, articular car- 
tilage with its extracellular matrix containing no lymphatic, ner- 
vous or vascular systems and only one cell type is considered tobe a stepping stone for the transition from simple cell to complex 
tissue cryopreservati on with high cell viability and function. Infor- 
mation gained from cryopreserv ation of articular cartilage can pro- 
vide valuable insight into more complex tissue and organ 
cryopres ervation.
In the following, a review of articular cartilage cryopreserv ation 
methods for transplantation is presented. First, the milestones of
cartilage cryopres ervation research are reviewed in chronological 
order, and the basics of associated injuries in classical cryopreser- 
vation methods for cartilage are discussed. Then, the prospect of
vitriﬁcation in lieu of classical cryopreserv ation, and the current 
status of cartilage cryopres ervation are reviewed . At the end, a
summary of challenges are presented and viable approaches are 
discussed.Cryopres ervation-assoc iated injuries in cartilage 
Successful cryopres ervation of articular cartilage is difﬁcult to
achieve due to general cryopreservati on challenges and some car- 
tilage-sp eciﬁc challenges. Tissues are more challenging to cryopre- 
serve than cellular systems in suspensi on for many reasons. In
tissues, both the cellular activity and the matrix structure must 
be preserved and this is complicated by the intimate relationshi p
of the cells with the extracellul ar matrix. Tissues generally contain 
multiple cell types each with different cryopres ervation parame- 
ters. Furthermore, different tissues have different requiremen ts
for transplanta tion. In some tissues, such as skin or bone grafts,
transplanta tion of the extracellular matrix is preferred without 
the native cells to decrease the risk of immunorejecti on in the re- 
cipient [12,42]. Alternativel y, some tissues such as articular carti- 
lage require the cellular system for proper long-term functioning 
of the extracellular matrix; therefore, the cryopreserv ation strat- 
egy must be able to minimize the damage to both the extracellul ar
matrix and the cells.Cryopreserva tion of isolated chondrocytes 
The earliest investigation into the preservation of chondro- 
cytes was done by Curran and Gibson (1956) [22] who investi- 
gated the radioactive sulfate uptake of chondroitin sulfate in
human chondrocytes as a measure of chondrocyte viability in
0.5 mm thick cartilage slices obtained from rib, ear or nose. They 
demonst rated that the cartilage can stay viable for up to 40 days 
in Tyrode solution at 4 C. However , cartilage slices, untreated or
pretreate d (with 10% to 30% w/w glycerol solutions), cooled 
down to 25 C showed no recovery of the chondrocytes. Heyner 
(1960) [40] trypsinized the cartilage for 25 min before slow and 
rapid freezing in 15% glycerol solutions. It appeared that the 
chondrocy tes in trypsinized cartilage could survive slow freezing 
to 79 C and grow in culture while the chondrocytes in untr- 
ypsinized cartilage could not tolerate freezing temperatures low- 
er than 20 C. It was concluded that the failure of the 
chondrocy tes to survive freeze–thaw protocols was related to
the cartilage matrix and cell-matrix interactions. Subseque nt re- 
search was performed on isolated chondrocytes to determine 
their ability to survive freeze–thaw protocols before spending 
more effort on the chondrocy tes in situ .
Unsucces sful freezing of cartilage slices by Curran and Gibson 
[22] (1956), followed by encouraging results from freezing of par- 
tially trypsinized cartilage by Heyner [40] (1960), led to cryopres -
ervation of isolated chondrocytes from rabbits, dogs, monkeys and 
human, by Smith (1965) [94], to avoid complications of dealing 
with a collagen matrix. Smith replaced glycerol with Me2SO and 
cooled the chondrocytes in 10% w/w Me2SO to 20 C at 1 C/
min followed by cooling at 4 C/min to 79 C, and found that 
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tained viability, assessed by physical appearan ce compared to a
control group, after thaw in a +40 C water bath. Chesterman and 
Smith (1968) [21] completed Smith’s study by transplanting the 
frozen–thawed chondrocytes into cancellous bone to evaluate cell 
function through growth rate. The chondrocytes were able to pro- 
duce a new cartilage matrix at the sites of resorption after 2 weeks.
This work answered the question of whether the chondrocytes can 
function properly after cryopres ervation. Despite this success,
there were more unknown s that needed to be addressed prior to
attempting to cryopreserve intact cartilage such as tolerable toxic- 
ity limits of chondrocytes.
Tomford et al. (1984) [101] isolated the chondrocytes from bo- 
vine articular cartilage to evaluate the toxicity limits of cryoprotec- 
tive agents (CPA) as a function of time, temperature and the 
concentratio n of the CPA. The toxicity of Me2SO can be due to
interactions with the lipid bilayer membran e of the cells [107]
and the intracellular enzymes [87]. Tomford et al. (1984) also 
investigated the optimum cooling rates for cryopreservati on of iso- 
lated bovine chondrocytes in a two stage slow- and rapid-cooling 
protocol following suggestions by Smith et al. (1965). In 1988,
McGann et al. [67] addresse d the role of cell membrane permeabil- 
ity to water as a key in the success of freezing protocols and 
combined computer simulatio ns with physical understanding of
the cell freezing process in designing cryopres ervation protocols 
for isolated chondrocytes. His works along with others resulted 
in successful cryopres ervation of chondrocy tes in slices. A protocol 
of 10% w/w Me2SO with 1 C/min slow-cooling was established 
for high recovery cryopreserv ation of isolated chondrocytes 
similar to many other cell types [68]. Schachar and McGann 
(1986) [90] reported 80–90% cell viability, assessed by membran e
integrity test, for isolated chondrocytes and approximat ely 50% for 
the chondrocytes in thin slices of cartilage using 10% Me2SO
and slow-cooling. With these successe s, the logical next step 
was to apply the same protocol to full-thick ness cartilage for 
transplanta tion.
Cryopreservati on of osteochondral plugs 
The discrepan cy in the success rates for isolated chondrocyte 
and in situ chondrocyte cryopreservati on led to studies on the ef- 
fect of ice formation on the chondrocytes in the cartilage matrix.
In search of an explanation for this inconsistenc y, Kawabe and 
Yoshinao (1990) [54] investigated the cryopreserv ation of in vitro 
rabbit articular cartilage slices using functional assays (by incorpo- 
ration of Na2SO4). They determined that diffusion was a signiﬁcant
factor with almost double the cell viability in the group with holes 
created in the matrix using a needle compare d to the group with 
normal matrix. Similar increases in cell viability were also noted 
after bone carrier alteration was performed by Jomha et al. [47].
Schachar et al. (1992) expanded on their success of cartilage slice 
cryopreserv ation [90] by using a rabbit model to investiga te the 
fate of the cryopres erved chondrocy tes in osteocho ndral allografts 
and autograft s after transplanta tion [89]. They showed that the 
chondrocytes in osteochond ral dowels cryopreserved in 7.5%
Me2SO and cooled at 1 C/min down to 70 C maintained 
some functional activity although it was signiﬁcantly less than the 
untreated control group at 12 months after transplanta tion.
Furthermore, these cryopres erved dowels demonstrat ed a thinner 
cartilage after 12 months indicating some breakdown of the carti- 
lage matrix suggesting that the functional activity of the chondro- 
cytes was insufﬁcient to maintain the matrix over the long-term. A
study by Tavakol et al. (1993) [100] investiga ted the changes in the 
ultrastructu re of chondrocytes in situ after a freeze–thaw cycle 
with and without Me2SO present using electron microscopy. The 
freeze–thaw condition s were similar to the study by Schachar et al. (1992). As expected, the chondrocytes in control samples 
without Me2SO were completely destroyed . Surprisingly, the chon- 
drocytes in the samples treated with Me2SO did not maintain a sig- 
niﬁcantly higher percentage of cellular structure integrity or cell- 
matrix junctions. Such results supported the assumption that the 
difﬁculty in cryopres ervation of chondrocy tes in situ after slow- 
freezing could be related to the loss of chondrocyte- matrix interac- 
tion, the altered extracellular matrix structure, and possibly the 
location of the chondrocytes within the matrix. Following that,
Muldrew et al. (1994) [73] investigated the localization of chon- 
drocyte viability in situ in osteochondral dowels in a sheep model 
using a graded freezing approach and 10% Me2SO. Prior to this 
work, chondrocyte viability was determined by isolating the chon- 
drocytes from the matrix and characterizi ng cell membrane integ- 
rity or biological function. This method was unable to reveal any 
informat ion regarding the distribut ion of the damaged and intact 
chondrocytes within the cartilage matrix. The study by Muldrew 
et al. suggested that the viability of the chondrocytes was depth- 
depende nt with the greatest damage in the middle zone. Ohlendorf 
et al. (1996) [79] later obtained a pattern of viable and injured cells 
similar to that of Muldrew et al. (1994) [73]. Both studies com- 
mented on the multiple reasons for observing such survival pat- 
terns but the main proposed reason was the association of
Me2SO diffusion with the thickness of the cartilage matrix. It was 
suggested that biologica l and biophysical reasons might exist for 
the apparent higher susceptibility of the chondrocytes in the mid- 
dle zone and that this could be investigated in more depth by mod- 
eling or measure ment of the stresses in the middle zone. In 2000,
Muldrew et al. published another study [75] on the ice morphology 
and its effect on the recovery of the chondrocytes . The results of
that study suggested two mechanism s of damage to the chondro- 
cytes and the matrix. First, the planar ice growth in the tissue is
limited by the diffusion of the solutes away from the ice front. This 
can cause supercooling in the tissue and perhaps spontaneou s ice 
nucleation within the lacunae. Second, ice formation can mechan- 
ically crush the cells, expand the pore size and disrupt the matrix,
as was demonst rated by scanning electron microscopy from frozen 
specimens . It was hypothes ized that the damage to the chondro- 
cytes could be in part due to ice formation in the lacunae where 
large amounts of water exists compared to within porositie s of
the collagen matrix (capillaries). Liu et al. showed that solutions 
in cartilage capillaries have lower freezing points than in larger 
spaces, and ice formation always starts from larger spaces within 
cartilage [63]. In 2001, Muldrew et al. showed that it is possible 
to achieve high recovery of the chondrocytes in ovine cartilage 
grafts using a 2-step cooling method [74]. However, large acellular 
regions and multicellular clumps of chondrocytes were observed in
the transplanted articular cartilage 3–12 months after transplanta- 
tion, suggesting an unknown type of cryoinjur y [72]. Unfortu- 
nately, the high cell recovery of this 2-step cooling method was 
not reproducibl e when using thicker human articular cartilage 
[50].
The effect of ice formatio n and vitriﬁcation on the cartilage ma- 
trix has been investigated . Laouar et al. demonstrat ed microstruc- 
tural changes due to ice formation in the cartilage matrix after 
Me2SO slow-cooling cryopreserv ation using MRI and biochemical 
analysis. Some protection was noted by the use of Me2SO [60].
Jomha et al. showed signiﬁcantly more ice formation using lower 
concentr ations of Me2SO (1 M) when compared to vitriﬁable con- 
centrations (6 M) where minimal matrix distortion was noted 
[48]. Further evidence for matrix damage was provided by Pegg 
et al. [82–84] in a series of comprehensive studies using the liqui- 
dus-track ing method previously introduce d by Farrant in 1965 [33]
for cellular cryopres ervation in suspension. The initial study dem- 
onstrated 56% recovery of chondrocyte viability and function in
0.7 mm thick discs of ovine articular cartilage cut from the bone 
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tracking vitriﬁcation of cartilage dowels increasing the recovery to
87% in the same ovine discs as the initial study [106]. According to
this study, ice formation within the chondrons was the major cause 
of cell viability loss during cryopreservati on. For a detailed analysis 
of the damage mechanisms in frozen articular cartilage , see the 
study by Pegg et al. [83].
From a clinical perspective, Song et al. (2004) evaluated the re- 
sponse of vitriﬁed cartilage grafts vs. slow-cooled grafts in rabbits 
and concluded that the vitriﬁed grafts performed signiﬁcantly better 
than the nonvitriﬁed group [95]. The results of these studies along 
with previous observations by Tavakol et al. (1993) and Muldrew 
et al. (2000) suggested that vitriﬁcation may be advantageous for 
preservation of cartilage over traditional slow-freezi ng. It is evident 
now that ice formation damages the matrix and alters cartilage 
mechanical properties through breakage and fragmentation of
ECM components including ﬁbronectin which can start the cascade 
of cellular injury by interacting with cell surface integrins and stim- 
ulate production of matrix-degr ading proteinases [35].
An alternative method of articular cartilage cryopreserv ation is
classical slow-cooling cryopreserv ation of cartilage using direc- 
tional freezing [8]. This technique is based on the assumption that 
uncontrolled ice crystal formation and propagat ion within the tis- 
sue is the major cause of damage, presumably due to mechanical 
crushing and electrolyte concentratio n. Norman et al. controlled 
the rate of freezing and planar ice front propagat ion in porcine car- 
tilage plugs using a state-of-the- art temperature-c ontrol system 
[77]. They reported cartilage health in terms of cell viability (53%
membrane integrity), functional assays (59% 35SO4 uptake) and 
biomechanical instantaneo us dynamic elastic modulus (62% of
fresh control). A human clinical study using the same method 
showed 47% viability post-thaw and pre-trans plant. Post-trans- 
plantation, there was an increase in the knee-speciﬁc scores in
the patients and plug incorporati on in 12 out of 18 patients [10].
As successfu l as these results may appear, they were not well- 
received by the surgical community because: (1) directional freez- 
ing, as performed , required injection of CPA into the cartilage using 
ﬁne 20 lm diameter needles, which distort the cartilage matrix 
upon insertion, (2) ice crystal formation, controlle d or uncon- 
trolled, is known to damage the matrix, the cells and cell-matrix 
junctions, and hence is not desirable , and (3) the reports men- 
tioned that the viability was limited to the superﬁcial layer of
the cartilage which is insufﬁcient to maintain the cartilage in the 
long-term. The 1-year follow-up study also mentioned that the 
elastic modulus of the cartilage was 40% compromi sed even before 
the transplanta tion and this important property of cartilage was 
not measured in the 1-year study as the human subjects were still 
alive and adequate sized biopsies were not possible [10].Is vitriﬁcation the ultimate answer? 
The current collective knowledge regarding successful cryopres- 
ervation of cartilage can be categorized into the following facts: (1)
articular cartilage needs to remain attached to the underlying bone 
during preservation for transplanta tion, (2) the thickness of articular 
cartilage plays a key role in the success of the cryopreserv ation pro- 
tocol, (3) isolated chondrocytes can be cryopreserv ed using 10% w/w 
Me2SO and 1 C/min cooling rate but this protocol does not work 
for chondrocytes in situ , (4) ice formation within the matrix plays 
a major role in chondrocy te loss during cryopreservati on, and (5)
ice formation mechanicall y disrupts the extracellular matrix which 
can cause post-thaw/p ost-transpla nt failure.
Vitriﬁcation is the transition of a solution from the liquid state 
into a glass-like solid state without forming any crystalline struc- 
ture, i.e. an amorphous solid. It can be achieved by fast cooling,or by addition of known concentrations of certain solutes, or both.
In cryobiology, vitriﬁcation involves introduction of high concen- 
trations of cryoprotect ive agents (CPA) – typically 30–60% w/w 
CPA – to the tissue [30,33]. If vitreous preservati on of cartilage 
can be achieved, then both the chondrocytes and the matrix can 
be preserved. Vitriﬁcation of pure water is only possible at very 
low volumes (of the order of cubic microns) and ultrafast cooling 
rates [14]. The size of the specimen can be a limitation on achiev- 
ing the desired cooling rates due to heat transfer. Addition of other 
solutes, such as CPAs, decreases the required cooling rate thus 
increasing the size of specimen that can be vitriﬁed. At certain high 
concentr ations, dependent on the type of CPA used, vitriﬁcation
can be obtained regardless of the cooling rate or size of the speci- 
men. Thus, there are three main obstacles to overcome for the suc- 
cessful vitriﬁcation of tissues: (1) CPA permeation, (2) CPA toxicity,
and (3) CPA vitriﬁability (obtaining sufﬁcient concentration to vit- 
rify and not devitrify during warming ).
It has been observed that ice formatio n is correlated with cell 
damage within the articular cartilage matrix [75,83]. Ice formation 
alters the collagen matrix and the proteoglyca n network by enlarg- 
ing pores and breaking the protein molecule chains 
[48,60,10 9,116] . Fahy et al. (1984) suggested that, upon successfu l
vitriﬁcation, the target tissue need not satisfy classical cryopreser- 
vation constrain ts, and can escape both intracellular freezing and 
the solution effects [30]. This was not adopted until other efforts 
of classical cryopreservati on of cartilage failed, as described in
the previous section. Upon successful vitriﬁcation, various prob- 
lems with regards to large tissue and organ cryopreservati on can 
be addresse d, including nonuniform cooling and warming rates –
which will not be controlled nor as fast as desirable – and ice for- 
mation. This was further accentuated by Pegg in an article pub- 
lished in 2001 in which it was suggested that, since vitriﬁcation
of large tissues (compared to cells) is only possible when CPAs 
are used in high concentr ations, vitriﬁcation would be the ultimate 
answer to the cryopreserv ation of tissues only when the cytotoxic -
ity of the CPA is properly addressed [81].
There are a considerabl e number of publications and patents on
the application of vitriﬁcation for tissue and whole organ preserva- 
tion including kidney [32], liver slices [29] and blood vessels [55].
Most tissues studied were either vascular or were organ slices, in
both cases the CPA equilibration time througho ut the tissue could 
be effectively reduced by the perfusion of the CPA solution or adjust- 
ing the tissue slice thickness [56]. The earliest accounts of vitriﬁca-
tion of articular cartilage are from Jomha et al. [45,46]. These two 
studies demonst rated 42% and 33% cell recovery respectively after 
vitriﬁcation using high concentratio ns of Me2SO. Song et al. achieved 
80% chondrocyte viability (Alamar Blue and calcein-AM ﬂuores-
cent functiona l assays) in vitriﬁed rabbit full thickness femoral head 
cartilage . Using cryosubstituti on, it was shown that vitriﬁcation, or
in other words ice-free cryopreservati on, was truly achieved [96].
In another study, scanning electron microscopy of the cartilage sam- 
ples immersed and fast-cooled in P6 M DMSO solution showed a
decrease in the size and total volume of the enlarged pores due to
ice formation [48]. Further evidence of the protection of extracellu- 
lar matrix from ice formation damage was provided by multiphoton 
ﬂuorescent imaging of cartilage grafts and Raman spectroscop y of
heart valve leaﬂets, concluding that the tissue extracellul ar matrix 
received more extensive damage when frozen with a conventional 
slow-freezi ng than when vitriﬁed [18,105].
Since the concentr ations required for vitriﬁcation are generally 
high, a number of studies have investigated CPA toxicity at high 
concentr ations in cartilage and other tissues providing some valu- 
able information although the data is far from complete. It is clear 
that CPA toxicity is species and tissue speciﬁc; therefore, these re- 
sults cannot be generalized [5,23,85,88,104,111] . There are few 
studies investigatin g the mechanis ms of toxicity and the effects 
A. Abazari et al. / Cryobiology 66 (2013) 201–209 205of high concentrations of CPAs [7,13,26,28,32,113] . More recently,
a few studies have investigated CPA toxicity speciﬁc to articular 
cartilage with some general trends in CPA toxicity to chondrocytes 
and CPA interactions developing [6,26,53]. The speciﬁcs of cellular 
toxicity are not clearly deﬁned at this point and methods of miti- 
gating toxicity of speciﬁc CPAs are not available ; however the gen- 
eral consensus in the ﬁeld of cryobiology is to expose cells to the 
CPA at the lowest concentratio n and temperature for the shortest 
exposure time possible so the formatio n of ice is avoided. This 
method is called liquidus tracking or stepwise loading and cooling.
Liquidus-tra cking and stepwise loading-cooling 
The ﬁrst notion of step-wise or continuous loading-coo ling in
the literature was in an article published in Nature in 1965 by Far- 
rant, where he suggested that the viability of cells in tissues could 
be sustained after cooling to temperat ures as low as 79 C, given 
that the increase in the concentr ation of electrolytes due to ice 
exclusion during cooling and freezing was avoided by continuous 
or step-wis e addition of CPAs, such as DMSO or glycerol, to the 
freezing medium [33]. This approach was motivated by evidence 
of electrolyte toxicity at high concentrations that occurred during 
freezing [64]. In fact, increased electrolyte concentration, particu- 
larly the sodium ion concentration, is found to have adverse effects 
on cell viability and homeostasi s in various aspects of biopreserva- 
tion by changing the ionization levels of the phospholipid head 
groups and their range of electrostatic interactions [44,99]. None- 
theless, even theoreticall y perfect protocols of cryopreservati on
did not result in 100% survival of cells all the time, which led Fahy 
to discuss the evidence of CPA toxicity as a major cause of inefﬁ-
ciencies in protocols of cryopres ervation for cells and tissues in
an article published in 1986 [27].
In liquidus-track ing, exposing cells to a low concentratio n of
CPA at the lowest temperature possible, i.e. 0 C, minimize s the 
concentratio n- and temperature -dependent toxicity of the CPA.
The time-depend ent toxicity of the CPA would depend on the rate 
of the CPA diffusion into the cells. Then the suspension of cells in
CPA can be cooled down to the freezing point of the solution to fur- 
ther suppress the temperature -dependent toxic effects. Sequen- 
tially, more CPA concentration is introduce d to the suspension 
and time is allowed for equilibration. The steps of concentratio n in- 
crease and temperat ure decrease continue until a vitriﬁable con- 
centration of the CPA is reached within the cells, at which point 
plunging the suspension of cells into liquid nitrogen vitriﬁes the 
system. This approach is feasible with cells in suspensi on consider- 
ing that the size of the cells is much smaller compare d to tissues 
(lm vs. mm). The CPA can cross the cell membran e and reach equi- 
librium within minutes [67,112]. In tissues, however , the time of
diffusion and equilibration of CPA can take hours depending on
the size and dimensions of the tissue [92] which is far too long 
for protocols suggested by Farrant in terms CPA cytotoxicity. Elford 
and Walter were ﬁrst to practice Farrant’s stepwise loading/coolin g
method using smooth muscle cells [24]. However, the interstitial 
concentratio n of the CPA at each step was unknown in that study.
In the last of a series of three papers by Pegg [82–84], he describes 
the ﬁrst perfectly performed actual liquidus-tracki ng method.
Discs of ovine cartilage with 0.7 mm thickness were vitriﬁed
through a 7-step vitriﬁcation protocol and the interstiti al concen- 
tration of the Me2SO at each step during loading and washing steps 
was carefully measured. The reported recovery of the chondro- 
cytes, about 57%, was assessed by 35S incorporation in a glycosami- 
noglycan (GAG) functional assay. Later, they reported up to 87%
and 70% of control 35S incorporati on for ovine and human discs,
respectively , using a continuo us stirring system [106]. It can be de- 
bated that functional assays can produce misleading results 
when performed on cellular systems as these cells can become metaboli cally more active after cooling stresses, as demonstrat ed
by the work of Jomha et al. [49]. These results were the ﬁrst posi- 
tive demonstrat ion of liquidus-track ing application in tissues;
however , it suffered from one signiﬁcant limitation: actual human 
cartilage with up to 5 mm thickness would require signiﬁcantly
longer times for equilibration of the CPA than cartilage discs with 
0.7 mm thickness. The equilibration time would be even longer 
when the cartilage -on-bone grafts are to be cryopreserv ed using 
this method as cartilage on bone has only half of the surface avail- 
able for CPA diffusion compared to a cartilage disc.
Single- versus multi-CPA solutions for vitriﬁcation
Using one type of CPA during stepwise cooling for vitriﬁcation
may be possible in thinner tissues as shown by Pegg but would result 
in excessive CPA toxicity in larger tissues because of the prolonge d
exposure to very high concentratio ns of the CPA during the ﬁnal
stages. This is complicated by the fact that for most CPAs, cytotoxic- 
ity increases nonlinearly with concentratio n [26]. Therefore, to de- 
crease concentration- dependent CPA cytotoxicity during cooling 
steps, another approach is to use combinations of CPAs each at a low- 
er ﬁnal concentr ation so that individually the CPAs are less toxic to
the cells but the overall ﬁnal concentratio n is sufﬁcient to vitrify 
[20,31,61]. The idea of cryoprotect ant toxicity neutralization using 
certain amides as structural analogues of cryoprotect ants was dis- 
cussed previously by Fahy [28]. Recently, Jomha et al. showed 
positive interactions between commonly used CPAs [6,53]. This 
indicates that a lowered cumulative CPA toxicity occurs in multi- 
ple-CPA solutions compared to single-CPA solutions of similar total 
concentr ation [53]. The same group showed that multiple-CPA solu- 
tions can be beneﬁcial by increasing the glass stability above that of
an equivalent molar single-CPA solution [108]. These conclusions 
were indirectly supported by Brockbank et al. (2010) [17] who re- 
corded good chondrocy te recovery after vitriﬁcation of pig articular 
cartilage using different combinations of Me2SO, formamide and 
propylen e glycol (VS55 and VS83 both loaded at 4 C followed by
cooling to 135 C at various cooling rates). Cartilage thickness re- 
mained an issue as the results showed increasingly lower recovery 
with thicker cartilage. Again in this study the cartilage had been re- 
moved from its bone base prior to vitriﬁcation.The current status of cartilage vitriﬁcation
To address three main obstacles to cartilage cryopreserv ation,
including CPA permeation to prevent ice formation within the ma- 
trix, CPA toxicity and CPA vitriﬁability, vitriﬁcation with multi-CPA 
solutions using stepwise cooling is perhaps the most viable ap- 
proach. Various aspects of the cryopreserv ation process must be
considered in order to develop a successful protocol, such as the ef- 
fect of cartilage thickness on the CPA distribution and loading/ 
equilibration time, inhomogeneity of matrix collagen orientation 
and proteoglycan distribut ion and its effect on the CPA permeabil- 
ity througho ut the depth of cartilage, and estimation of collective 
CPA toxicity/solutio n effects as a function of temperature , concen- 
tration and exposure time (dose response).
Measurem ent of CPA diffusion in cartilage 
Different measurement methods have been used by researchers 
to gain an understand ing of the diffusion rate of speciﬁc CPAs in
cartilage and similar tissues. Sharma et al. [92] and Jomha et al.
[51] calculated the overall uptake of four commonly used CPAs in
cartilage discs by measuring the osmolality of a known amount 
of phosphate-b uffered saline in which the treated cartilage disc 
had been equilibrated over 24 h. Using a similar approach, Pegg 
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to measure Me2SO content in discs of cartilage. Wusteman et al.
[113] did not directly measure the overall concentratio n, but used 
differential scanning calorimetry (DSC) to measure the melting 
point of the tissue sample after freezing for direct applicati on in
their step-cooling protocol. In a few other studies, magnetic reso- 
nance imaging (MRI) has been used to evaluate the overall CPA 
content of the tissue [34,43,80]. Mukherjee et al. (2008) used 
MRI to obtain total Me2SO concentration in cartilage dowels [71].
The data acquired in these experiments were either used directly 
in the design of the stepwise protocols, or were fed to models such 
as Fick’s law of diffusion to calculate the effective diffusion coefﬁ-
cient of the CPA in cartilage for making further predictions. The 
study by Isbell et al. [43] was the ﬁrst to demonstrat e the possibil- 
ity of collecting spatially resolved data of the dynamics of CPA 
diffusion in rat kidney and liver tissues. However, the application 
of the acquired data was limited to the calculatio n of an effective 
diffusion coefﬁcient in the tissue. A recent study by Abazari et al.
(2012) was the ﬁrst to experimentally spatiotemp orally resolve 
the uptake of Me2SO in cartilage dowels during the course of a
1-h experiment using MRI [3]. The data presented in that study 
showed that the heterogeneitie s in cartilage matrix collagen and 
GAG protein network have minimal effect on the distribution of
a nonionic solute such as Me2SO, and that, in full-thicknes s healthy 
porcine cartilage, the diffusion of Me2SO is not signiﬁcantly hin- 
dered due to matrix orientation and density across the thickness,
and that the diffusion is abruptly impeded at the bone-carti lage 
interface, as previously suggested [78].
Modeling CPA transport in cartilage 
A nonuniform distribution of CPA due to the thickness produces 
a subsequent nonunifo rm pattern of damage, so that the chondro- 
cytes may survive in some regions while experiencing more dam- 
age in other regions. This makes it even more difﬁcult to analyze 
the CPA toxicity effects during loading. Therefore, minimizatio n
of the exposure time of the tissue to the CPA is a necessity for min- 
imal damage to the cells in the tissue. In a CPA-loading protocol,
steps must be designed to minimize the exposure time at each 
temperature . Therefore, knowledge of CPA diffusion in cartilage,
by measure ment or by calculation, is required for the design of
effective and efﬁcient CPA-loading protocols. However, modeling 
efforts for predictin g CPA diffusion in tissues such as articular car- 
tilage have been few and limited until recently. Muldrew et al.
used Fick’s law to calculate the diffusion coefﬁcient of the Me2SO
in cartilage for further predictin g the overall Me2SO uptake in car- 
tilage over time [76]. Maxwell–Stefan transport equations were 
used by Xu and Cui (2003) in modeling the co-transpor t of multiple 
solutes in a porous media for applications in tissues such as carti- 
lage [114] – Maxwell –Stefan equations are a more sophistic ated 
set of equations from which Fick’s law can be derived using some 
simplifying assumptions including an ideal-dilute assumpti on for 
solutes. Two different studies were published in 2008 by Zhang 
and Pegg [115] and Mukherjee et al. [71] on modeling CPA diffu- 
sion in cartilage. Mukherje e et al. used Fick’s law of diffusion to
predict the spatial and temporal distribution of the CPA in carti- 
lage. That information was further used to design hypotheti cal 
stepwise cooling protocols and predict the chondrocyte volume re- 
sponse to CPA loading. Lawson et al. used the same approach to
simulate stepwise loading and removal of CPA from tissues [62].
These predictions are of high practical importance for designing 
and optimizing liquidus-track ing or stepwise loading-coo ling 
steps. Whether or not Fick’s law is capable of making accurate pre- 
dictions is another important question. To answer this question,
Zhang and Pegg [115] utilized the triphasic model of cartilage by
Lai et al. [59], developed in the biomechanical engineeri ng ﬁeld,to describe the movement of the CPA in cartilage . As novel as the 
study by Zhang and Pegg was, some of the assumptions were insuf- 
ﬁcient for the speciﬁc case of vitriﬁcation solutions, and basically 
reduced the model to Fick’s law. For example, the assumption of
ideal and dilute solutions for vitrifying concentratio ns of the CPA 
was insufﬁcient. Also, osmotic movement of the interstiti al ﬂuid
was ignored in the analysis. In addition, in part due to lack of
appropriate data, no values were reported for the transport param- 
eters of the model other than the diffusion coefﬁcient of the CPA.
Therefore, the ﬁnal conclusion of the study was that there were 
no essential differences between the biomechani cal model and 
Fick’s law in calculating transport in cartilage. Abazari et al.
(2009) took the biomechani cal model one step further by including 
non-idea l solution thermod ynamics and by incorporating appro- 
priate data (not only measure d overall concentration in the carti- 
lage disk but also its weight change) and were able to calculate 
transport paramete rs of the biomechanical model [2]. Later, they 
incorporate d the natural collagen and GAG network inhomogene i-
ties into the model to calculate a more realistic set of parameters,
and show that during CPA loading, cartilage undergoes a shrinking 
stress resulting from osmotic water loss from within the tissue to- 
ward the surrounding solution [4]. A recent study by the same 
group, comparing spatially and temporally resolved measureme nts 
with Fick’s law and the new biomechanical model, showed that the 
CPA distribut ion can be signiﬁcantly underestimate d when using 
Fick’s law [3]. Such underestimati on can result in longer than nec- 
essary CPA exposure of the chondrocytes within the matrix hence 
increasing the time-dep endent toxicity of the CPA.
Dehydrat ion and osmotic stresses during CPA loading 
During CPA loading to cartilage from a concentrated surround- 
ing solution, there is an osmotic water ﬂow to and from the carti- 
lage when exposed to solutions of different osmolalities which 
causes shrinking and swelling of articular cartilage during the 
CPA loading (and removal) which was not accounted for in the 
cryobiology literature before the works of Abazari et al. [2,4]. In
the context of biomechanical engineering, however, this water 
movement is known and included in the triphasic model of carti- 
lage under mechanical or osmotic stress [39,59,70]. Cartilage 
exhibits osmotic behavior similar to biological cells when exposed 
to different tonic environments : it swells and shrinks when ex- 
posed to hypo- and hyperton ic solutions. The osmotic propertie s
of cartilage are due to the presence of speciﬁc proteins within 
the cartilage matrix called proteoglyca ns. It is known that these os- 
motic properties contribute to the weight-beari ng properties of
articular cartilage by partially balancing the mechanical stress 
[69]. When cartilage is exposed to concentrated CPA solutions, it
shrinks and dehydrates due to osmotica lly-driven water move- 
ment from the matrix to the solution. The extent of the shrinkage 
and the resultant stress–strain in the tissue matrix and effects on
the chondrocytes may be important issues as described by Abazari 
et al. [4]. Also, after the diffusion of the CPA into the interstitial 
ﬂuid, the tissue gains back the volume and swells. This shrink- 
swell behavior can be repeated a few times when cartilage is trea- 
ted in a multistep loading protocol. In the biomechanical engineer- 
ing literature, the adverse effect of cyclic mechanical stress and 
strain in the tissue matrix on the chondrocytes has been demon- 
strated [57]. Also, dehydration of cartilage and concentr ation of
the salt ions in the interstiti al ﬂuid and the diffusion of the CPA 
into the cartilage change the osmotic environment of the chondro- 
cytes [4]. The osmotic stresses on the chondrocytes under CPA 
loading protocol conditions have generally not been considered 
important in the ﬁeld of cryobiology. It has been observed that os- 
motic dehydration causes a signiﬁcant decrease in cellular activity 
[91]. Simulation results for stress–strain in the cartilage matrix 
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middle and deep cartilage may experience a signiﬁcant mechanical 
stress due to outward osmotic water ﬂow, which would also inﬂu-
ence the interstitial ionic environment, resulting in an hyperos- 
motic environment for chondrocytes [4]. Such modeling results 
can provide an explanation for some unexpected outcomes seen 
in other studies, where in transplantation follow-up studies, only 
chondrocytes in the superﬁcial layer survived while the middle 
and deep layers were observed to be acellular [72,74].Summary of the challenges and suggested approaches 
Both the cellular system and the ultrastructu re of the cartilage 
matrix are required to be efﬁciently preserved for any cryopre- 
served-carti lage transplant to be successful in the long term. To
achieve this, vitriﬁcation is the approach that has been successfu l.
For vitriﬁcation of cartilage , where no vascular system exists to
facilitate the CPA transport into deep cartilage , the major hurdle 
is CPA permeation into thick cartilage, during which the chondro- 
cytes are exposed to potential CPA cytotoxic effects. The eventual 
answer to the thickness problem requires a combinati on of the fol- 
lowing approaches: (1) stepwise loading-coo ling, whereby 
decreasing the cartilage -bath system temperat ure to reduce the 
cytotoxic effects is in concert with the increase in CPA concentra- 
tion as the CPA is gradually introduced, and (2) use of multiple- 
CPA solutions instead of single-CPA solutions. It must be noted that 
an adverse effect of the liquidus-track ing method is that, since the 
CPA diffusion rate has an Arrhenius temperature dependence, low- 
ering the temperature also slows down the rate of CPA transport 
within the tissue. For example, the Fickian diffusion coefﬁcient
for Me2SO decreases by 25% going from 0 C to 10 C [51]. This 
temperature dependence is even more signiﬁcant for some other 
common CPAs such as glycerol and propylene glycol, which de- 
crease about 50% within the same temperature range [51]. This 
means that longer diffusion times are needed to reach the same de- 
sired concentratio n, which also means longer exposure of the 
chondrocytes to the CPA, hence higher toxicity. Additional infor- 
mation that is important to improve the success of vitriﬁcation
protocols includes: (3) dose-depend ence of CPA cytotoxicity,
which is required to be clearly deﬁned as a function of tempera- 
ture, concentratio n and exposure time, and (4) modeling, which 
will facilitate the design of loading protocols and will greatly re- 
duce the number of trial and error experiments .
Recently, successfu l vitriﬁcation of intact human articular carti- 
lage on its bone base has been achieved by Jomha et al. [52] by
incorporation of all the aforementione d elements. Early work with 
single-solut ion high concentrations of Me2SO (Jomha et al. [45,46])
resulted in moderate cell recovery after vitriﬁcation and was fol- 
lowed by investigatio ns into CPA permeation kinetics [2,51,92],
CPA toxicity kinetics [6,26,53] and CPA vitriﬁability [108]. The data 
gathered from these studies, combined with the ability to calculate 
freezing points of multi-CPA solutions [25,86], was incorporated 
into a stepwise vitriﬁcation protocol where four CPAs were added 
at progressively lowered temperat ures until 6.5 M concentratio n
was reached [52]. The tissue consisted of 10 mm diameter osteo- 
chondral dowels (cartilage on the bone) as well as larger fragments 
approximat ing 12.5 cm2 and was obtained from knee replacemen t
surgeries as well as normal articular cartilage from deceased do- 
nors. The tissue was vitriﬁed in liquid nitrogen for up to 3 months.
Cell recovery was over 75% on 18 different samples from 10 differ- 
ent human knee replacement surgery donors with similar results 
from large fragments, normal cartilage from deceased donors and 
after storage for 3 months in one sample [52]. Cell viability was 
determined by membrane integrity stains as well as a mitochon- 
drial assay and a functiona l assay consisting of pellet culture ofthe cells followed by staining for cartilage speciﬁc sulfated proteo- 
glycans and collagen type II [52].
This paper has presente d a review of some of the important 
understa nding that has been gained in the area of articular carti- 
lage cryopreservati on, from early work on the cryopreserv ation 
of isolated chondrocytes in the 1950s and 1960s through to recent 
reports of vitriﬁcation of articular cartilage of various species both 
removed from the bone and intact with its bone base.
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